HYSTERECTOMY, OOPHORECTOMY, AND SUBSEQUENT OVARIAN-CANCER RISK

被引:0
|
作者
PARAZZINI, F
NEGRI, E
LAVECCHIA, C
LUCHINI, L
MEZZOPANE, R
机构
[1] UNIV LAUSANNE, INST SOCIAL & PREVENT MED, CH-1000 LAUSANNE 17, SWITZERLAND
[2] UNIV MILAN, OSTET & GINECOL CLIN 2, I-20122 MILAN, ITALY
来源
OBSTETRICS AND GYNECOLOGY | 1993年 / 81卷 / 03期
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To analyze the relation between hysterectomy with or without oophorectomy and the risk of subsequent ovarian cancer. Methods: We have conducted a case-control study since 1983 in a network of general and university hospitals in the greater Milan area. The cases were 953 women aged less than 75 years with histologically confirmed epithelial ovarian cancer. Women younger than 75 years residing in the same geographic area and admitted for acute conditions to the same network of hospitals where the cases had been identified were eligible as controls. Potential controls were excluded if they had been admitted for gynecologic, hormonal, or neoplastic diseases or had previously undergone bilateral oophorectomy. A total of 2758 controls were interviewed. Results: Fifty-two cases (5.5%) and 215 controls (7.8%) reported a history of hysterectomy, including eight cases and 38 controls who also reported unilateral oophorectomy. In comparison with women with intact uterus and ovaries, the age-adjusted relative risk (RR) was 0.7 in both women who reported hysterectomy alone (95% confidence interval [CI] 0.5-0.9) and in those reporting hysterectomy plus unilateral oophorectomy, though the latter finding was not statistically significant (95% CI 0.3-1.4). The risk of ovarian cancer was inversely related with time from hysterectomy. Compared with women reporting no pelvic surgery, the RR was 0.9 (95% CI 0.4-1.7), 0.7 (0.3-1.6), 0.7 (0.3-1.4), and 0.5 (0.3-0.8), respectively, in women reporting hysterectomy within 4 years or less and 5-9, 10-14, and 15 years or more before interview. Conclusion: Hysterectomy approximately halves the risk of ovarian cancer, possibly because of altered ovarian blood flow or the opportunity that hysterectomy provides for examining the ovaries.
引用
收藏
页码:363 / 366
页数:4
相关论文
共 50 条
  • [31] Role of prophylactic oophorectomy at the time of hysterectomy in ovarian cancer prevention in Thailand
    Charoenkwan, K
    Srisomboon, J
    Suprasert, P
    Phongnarisorn, C
    Siriaree, S
    Cheewakriangkrai, C
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2004, 30 (01) : 20 - 23
  • [32] Ovarian cancer incidence and death in average-risk women undergoing bilateral oophorectomy at benign hysterectomy
    Cusimano, Maria
    Ferguson, Sarah
    Chiu, Maria
    Moineddin, Rahim
    Aktar, Suriya
    Liu, Ning
    Baxter, Nancy
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S224 - S224
  • [33] SUBSEQUENT PRIMARY CANCERS IN RELATION TO TREATMENT OF OVARIAN-CANCER
    PRIOR, P
    POPE, DJ
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (03) : 453 - 459
  • [34] INCOMPLETE PREGNANCIES AND OVARIAN-CANCER RISK
    NEGRI, E
    FRANCESCHI, S
    LAVECCHIA, C
    PARAZZINI, F
    [J]. GYNECOLOGIC ONCOLOGY, 1992, 47 (02) : 234 - 238
  • [35] LACTATION AND THE RISK OF EPITHELIAL OVARIAN-CANCER
    ROSENBLATT, KA
    THOMAS, DB
    BERRY, G
    MACLENNAN, R
    SHEARMAN, R
    JELIHOVSKY, T
    BOOTH, JC
    MOLINA, R
    MARTINEZ, L
    SALES, O
    DABANCENS, A
    CHEN, ZH
    TAO, Y
    HU, YW
    MODAN, B
    RON, E
    ALFANDARY, E
    CUEVAS, HR
    SALAZAR, SB
    PALET, A
    ONTIVEROS, P
    APELO, RA
    DELACRUZ, JR
    BAENS, J
    JAVIER, B
    PARDTHAISONG, T
    MARTIN, N
    THEETRANONT, C
    BOOSIRI, B
    CHUTIVONGSE, S
    VIRUTAMASEN, P
    WONGSRICHANALAI, C
    JIMAKORN, P
    KOETSAWANG, S
    RACHAWAT, D
    KOETSAWANG, A
    SCULLY, RE
    YOUNG, RH
    THOMAS, DB
    ROSENBLATT, KA
    NOONAN, EA
    HOLCK, S
    FARLEY, T
    MEIRIK, O
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (02) : 192 - 197
  • [36] GALACTOSE CONSUMPTION AND RISK OF OVARIAN-CANCER
    REICHLIN, S
    [J]. LANCET, 1989, 2 (8662): : 565 - 565
  • [37] AGE - IS IT A RISK FACTOR IN OVARIAN-CANCER
    PARK, RC
    [J]. CANCER, 1994, 73 (02) : 245 - 246
  • [38] WOMAN AT RISK FOR DEVELOPING OVARIAN-CANCER
    MCGOWAN, L
    PARENT, L
    LEDNAR, W
    NORRIS, HJ
    [J]. GYNECOLOGIC ONCOLOGY, 1979, 7 (03) : 325 - 344
  • [39] FERTILITY DRUGS AND RISK OF OVARIAN-CANCER
    WHITTEMORE, AS
    [J]. HUMAN REPRODUCTION, 1993, 8 (07) : 999 - 1000
  • [40] CYTOREDUCTION IN OVARIAN-CANCER - WORTH THE RISK
    MACFEE, MS
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 1988, 55 (06) : 511 - 512